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RES 133T RESPIRATORY CARE PHARMACOLOGY 
COURSE SYLLABUS 
 
 
INSTRUCTOR:  Charles Miller 
 
DAYS/TIME:   
 
COURSE DESCRIPTION:  Introduction to pharmacology as related to the 
cardiopulmonary system.  Emphasis is placed on drug 
receptor sites, mechanism of action of bronchoactive, 
and cardiotonic drugs, that are seen or used by 
Respiratory Care Practioners 
 
PREREQUISITE:  RES 133T 
 
TEXT:  Cottrell G P, Surkin HB. Pharmacology for Respiratory 
Care Practitioners.  1995 F.A. Davis Company (out of 
print) 
 
ATTENDANCE/ 
EVALUATION:   Attendance is required for all scheduled examinations 
and  quizzes.  There are no make-up 
examinations or quizzes.  If   you are unable to take 
the scheduled examination, you must   make 
arrangements to take the examination prior to the   
 scheduled examination.  In cases of emergency, the 
examination 
will be taken on the first day of return. 
 
GRADING SCALE: 
 
A   = 4.00 95-100%  B-  = 2.67 80-83%  D+ = 1.33 67-69% 
A- = 3.67 90-94%   C+ = 2.33 77-79%  D   = 1.00 67-69% 
B+ = 3.33 87-89%   C   = 2.00 74-76%  D-  = 0.67 60-63% 
B   = 3.00 84-86%   C-  = 1.67 70-73%  F    = 0.00 
 
Students in Respiratory Care program must have a “B-“ final grade in order to progress within the 
program.  Test questions will be based on unit objectives. Unit objectives are to be used as study 
guides. 
 
HOMEWORK:   Your homework must be turned in on the assigned class 
day.  For math problems, write the formula, derivation of 
the answer, and box the answer with the appropriate 
units of measurement for full credit.  No credit may be 
given for late work.  Returned homework will be placed 
in the drawer of the overhead projector stand for 
absentees. 
 
TEST PROCEDURE:   Standard testing policy will be adhered to.  No talking, 
no papers on desk, every other chair occupied.  You 
should not leave the room during the exam period.  
Occasional quizzes may be given. 
 
CLASSROOM 
ETIQUETTE:   Please refrain from talking to each other during lectures.  
 Do not leave or arrive late to the 
classroom as previous students have stated this is very 
distractive. 
OTHER POLICIES: 
 
Academic Misconduct: All students must practice academic honesty.  Academic 
misconduct is subject to an academic penalty by the 
course instructor and/or a disciplinary sanction by the 
University. 
 
All students need to be familiar with the Student 
Conduct Code.  The Code is available for review online 
at http://www.umt.edu/SA/VPSA/index.cfm/page/1321. 
 
Disabilities: Eligible students with disabilities will receive 
appropriate accommodations in this course when 
requested in a timely way.  Please speak with me after 
class or in my office.  Please be prepared to provide a 
letter from your DSS Coordinator. 
COURSE OUTLINE: 
 
I. The Physiologic Basis of Drug Action 
A. Pharmaceutical Phase 
B. Pharmacokinetic Phase 
C. Pharmacodynamic Phase 
 
II. Drugs Affecting the Peripheral Nervous System 
A. Neurochemical Transmission 
B. Autonomic Pharmacology 
C. Cholinergic Agonists 
D. Nicotinic Antagonists 
E. Muscarinic Antagonists 
 
III. Drugs Affecting the Respiratory System 
A. Allergic Mediators 
B. Antiallergics and Antihistaminics 
C. Antimuscarinic Bronchodilators 
D. Adrenergic Agonists 
E. Xanthine Bronchodilators and Ventilatroy 
Stimulants 
F. Glucocorticoids 
G. Mucokinetic, Surface-Active and Antitussive 
Agents 
H. Antibacterials 
I. Antivirals, Antifungals, and Antiprotozoals 
 
IV. Drugs Affecting the Cardiovascular System 
A. Cardiotonics 
B.   Nitric oxide 
C. Antianginals 
D. Antiarrhythmics 
E.   Antithrombotics and Thrombolytics 
F.   Diuretics 
     
V. Drugs Affecting the Central Nervous System 
      A.   Conscious Sedation 
      B.   Analgesics 
      C.   Local Aneshetics 
      D.   Narcotic Antagonists  
 
 
